PSG invested in DoseSpot, a SaaS platform for clinicians to transmit prescriptions to pharmacies. The investment will help DoseSpot expand its ability to support customers and build up its user base.
PSG invests in clinician SaaS platform DoseSpot
PSG managing director Bill Skarinka; principal Chris Andrews; and Chris Collins, vice president, joined DoseSpot’s board, along with Brian Kelly, a senior adviser working with PSG.
